Results 61 to 70 of about 22,928 (253)
Head &Neck, EarlyView.ABSTRACT Background Preirradiated patients undergoing microvascular head and neck reconstruction for tumor recurrence or osteoradionecrosis (ORN) face surgical site infection (SSI) rates exceeding 30%. The impact of perioperative extended‐spectrum antibiotic coverage remains unclear. This study hypothesizes that calculated prophylaxis with piperacillin/
Johannes G. Schuderer +11 more
wiley +1 more source
Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model [PDF]
Acta Cirúrgica Brasileira, 2016 PURPOSE : To evaluate a modified experimental model for medication-related osteonecrosis of the jaw (MRONJ) through the upper right central incisor extraction followed by intravenous bisphosphonate administration. METHODS: Forty five rats underwent the
Cláudia Curra +7 more
doaj +1 more source
Bisphosphonate-related osteonecrosis of the jaws (Bronj) [PDF]
, 2013 Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is an extremely therapy resistant osteomyelitis-like disease exclusively involving the jaw bones of patients in treatment with bisphosphonates (BPs).
Beninatio, Francesco +2 more
core +1 more source
Review of: "Italian Position Paper (SIPMO-SICMF) on Medication-Related Osteonecrosis of the Jaw (MRONJ)" [PDF]
, 2023 Gianfilippo Nifosì
openalex +3 more sources
Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
Креативная хирургия и онкология, 2022 The occurrence of drug-induced osteonecrosis of the jaw in cancer patients treated using bone-modifying medications (bisphosphonates and denosumab) is a highly relevant research problem studied by dentists, maxillofacial surgeons, and oncologists ...
E. M. Spevak +3 more
doaj +1 more source
Position Papers on MRONJ(Medication related osteonecrosis of the jaw), What has changed? [PDF]
, 2023 Tae‐Geon Kwon
openalex +1 more source
Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws: a review of the literature [PDF]
, 2016 Background: Bisphosphonates (BPs) and other antiresorptive agents such as denosumab are widely prescribed for the treatment of osteoporosis and are also used in patients with multiple myeloma and metastatic breast or prostate cancer for avoiding bone ...
Bagán Sebastián, José Vicente +1 more
core +1 more source
Revista medica de Chile, 2021 Medication-related osteonecrosis of the jaw is a disease where there is necrotic bone exposed or that can be explored by means of a fistula in the maxillofacial region. It has been associated with the use Biphosphonates and denosumab for osteoporosis. Although its etiology is unclear, it may be related to a decrease in bone turnover produced by these ...
Camila, Foncea +7 more
openaire +1 more source
Cancer Science, EarlyView.The KYUCOG‐1901 prospective multicenter study evaluated radium‐223 in 93 Japanese patients with bone‐metastatic castration‐resistant prostate cancer. Ra‐223 was well tolerated, produced meaningful declines in ALP, and yielded a median overall survival of 23.0 months. Early initiation in patients with lower disease burden and integration with subsequent
Masaki Shiota +12 more
wiley +1 more source
Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat [PDF]
, 2018 OBJECTIVES: Pathogenesis of bisphosphonate-related osteonecrosis of the jaws (BRONJ) is not fully explained. An antiangiogenic effect of bisphosphonates (BPs) or an altered bone quality have been advocated.
D. Chappard +4 more
core +1 more source